hemolysis

Documents about hemolysis

• HEMolysis in a Percutaneous Axial Flow LVAD, Effects of Pentoxifylline in a Randomized Controlled Trial#857438ClinicalTrials.gov
• Isoagglutinins in the Development of IVIG-associated Hemolysis#1409730ClinicalTrials.gov
• Feasibility Performance Study of ABL90 FLEX PLUS HEM#1439319ClinicalTrials.gov
• Protective Effect of Propofol Against Hemolysis in Patients Submitted to Gastroplasty#904577ClinicalTrials.gov
• Clinical Study of a Novel Hemolysis Point of Care Test at an Emergency Department.#1046137ClinicalTrials.gov
• Danicopan Early Access Program#993382ClinicalTrials.gov
• Optimization of hemolysis index thresholds for biochemical and immunoassays#1399640HAL (France)
• Pilot Study to Assess Safety, Preliminary Efficacy and Pharmacokinetics of S.C. Pegcetacoplan (APL-2) in PNH Subjects.#1075179ClinicalTrials.gov
• Modified Diagnosis and Treatment of Neonatal Hemolysis With ETCOc in sNH#1362773ClinicalTrials.gov
• Probiotic Ingestion and Isoagglutinin Titers#828762ClinicalTrials.gov
• Dietary Fiber and Hyperkalemia in Dialysis Patients#1378505ClinicalTrials.gov
• Effects of Nitric Oxide on the Endothelium During Hemolysis.#1475907ClinicalTrials.gov
• Pneumatic Tube System Versus Personnel Transport and the Hemolysis Index of Emergency Department Blood Samples: A Randomized, Split-Sample, Single-Blind Trial#1485495ClinicalTrials.gov
• Measurement of Carboxyhemoglobin by Gas Chromatography as an Index of Hemolysis#903169ClinicalTrials.gov
• A Test to Predict the Hemolytic Potential of Drugs in G6PD Deficiency#1421122ClinicalTrials.gov
• A new pitfall in potassium testing: A case series of false elevation of hemolysis index in the presence of monoclonal protein#670012HAL (France)
• Causes and Mechanisms of Space Hemolysis At High Altitudes#873787ClinicalTrials.gov
• Is There Intravascular Hemolysis in Patients With Pulmonary Hypertension?#1365728ClinicalTrials.gov
• Diet Therapy in Hemodialysis Patients#1410491ClinicalTrials.gov
• Study to Assess the Incidence of Hemolysis, Safety, and Efficacy of Tafenoquine (SB-252263, WR238605) Versus Primaquine in Subjects With Plasmodium Vivax Malaria#1310076ClinicalTrials.gov
• Exploring carboxyhemoglobin as a predictive marker of hemolysis-related CSA-AKI#448861HAL (France)
• Cerebrospinal fluid hemolysis precedes secondary brain injury after aneurysmal subarachnoid hemorrhage#1242659bioRxiv / medRxiv
• New Hemolysis Parameters in Sickle Cell Disease#1349207ClinicalTrials.gov
• Meropenem and Piperacillin Plasma Concentrations During CRRT#802210ClinicalTrials.gov
• Cerebrospinal fluid hemolysis precedes secondary brain injury after aneurysmal subarachnoid hemorrhage#1090034Europe PMC
• Sildenafil To Prevent Clot#1385225ClinicalTrials.gov
• Danicopan as Add-on Therapy to a C5 Inhibitor in Paroxysmal Nocturnal Hemoglobinuria (PNH) Participants Who Have Clinically Evident Extravascular Hemolysis (EVH)(ALPHA)#1340363ClinicalTrials.gov
• Changes of Ocular Structures After Hemodialysis in Patients With Chronic Kidney Diseases#810305ClinicalTrials.gov
• Evaluation of a Blood Potassium Measurement Device From Capillary Samples (ALPHA)#1196850ClinicalTrials.gov
• Ravulizumab in Pregnancies Complicated by Severe Hypertensive Disorders#1464591ClinicalTrials.gov
• Use of Inhaled Nitric Oxide to Prevent Pulmonary Hypertension Associated to Stored Blood Transfusion#261387ClinicalTrials.gov
• Hereditary Spherocytosis and Vascular Function#852160ClinicalTrials.gov
• An Open Label Study of the Effects of Eculizumab in CD59 Deficiency#1009714ClinicalTrials.gov
• Post-artesunate Delayed Hemolysis in African Children With Severe Malaria: Incidence, Medical Impact and Prevention#1188952HAL (France)
• Erythrocyte Glutamine Level Relation to Pulmonary Hypertension Risk in Beta Thalassemia Major Children#287445ClinicalTrials.gov
• The Effect Of Vıdeo-Based Fıstula Care Educatıon On Hemodıalysıs#845305ClinicalTrials.gov
• Glutamine Therapy for Hemolysis-Associated Pulmonary Hypertension#918357ClinicalTrials.gov
• Restless Leg Syndrome: Is There a Response to Buddhist Walking Meditation in Hemodialysis#1408543ClinicalTrials.gov
• A Phase I Study to Assess the Safety of Pegcetacoplan (APL-2) as an Add-On to Standard of Care in Subjects With PNH#862056ClinicalTrials.gov
• Protective Antibody Level After COVID-19 Vaccination Among Patients Under Hemodialysis#125919ClinicalTrials.gov
• Immunogenicity and Safety of BBIBP-Corv Coadministered With PPV23 and IIV4 in Hemodialysis Population#474809ClinicalTrials.gov
• Home Hemodialysis Assisted by a Nurse for Arterio-venous Fistula Cannulation#1056901ClinicalTrials.gov
• Effect of Haemodialysis on the Efficacy of Antiplatelet Agents#1103126ClinicalTrials.gov
• Measuring the Plasmodium falciparum HRP2 protein in blood from artesunate-treated malaria patients predicts post-artesunate delayed hemolysis#1188947HAL (France)
• Carbon Monoxide Monitor for the Measurement of End-Tidal Carbon Monoxide Levels in Children With or Without Hemolysis#874596ClinicalTrials.gov
• Basophilic Stippling Unmasks Pyrimidine 5′‐Nucleotidase Deficiency in a G6PD ‐Deficient Patient#983849HAL (France)
• Performance of GFAP and UCH-L1 compared to S100B in detecting intracranial injury: influence of age, hemolysis, neurodegenerative diseases, and extracranial fractures in a prospective cohort of over 1,000 patients#11598HAL (France)
• CPB Prime Fluid Strategies to Preserve Mcirocirculatory Perfusion#834999ClinicalTrials.gov
• Warmed Blood Transfusion in Premature Infants#902494ClinicalTrials.gov
• Comparison and evaluation of the methods for measuring hemolytic activity of Stomolophus meleagris jellyfish tentacle extract#392069IRIS